Dr. Roberto Sotolongo, MD

Dr. Sotolongo practices at South Miami Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Sotolongo's NPI, 1013166156, was assigned on September 12, 2008. Dr. Sotolongo holds Florida license ME102263.

Dr. Sotolongo's primary practice is South Miami Hospital, at 6200 Sw 73rd St, Miami, FL 33143 in Miami-Dade County. The practice phone is (786) 662-4000.

Dr. Sotolongo's primary practice is South Miami Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Sotolongo is also affiliated with Cape Coral Hospital. The medical group on file is First Docs. Dmand AI also links Dr. Sotolongo to 3 more hospitals, 4 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sotolongo practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sotolongo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sotolongo is licensed in Florida.

CMS data shows 409 Medicare services from Dr. Sotolongo across 3 procedure codes in 2024, for 168 Medicare patients. Medicare paid $33,543 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Dr. Sotolongo in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sotolongo's median patient age at 74, with 58% women.

In 2023, Dr. Sotolongo wrote 111 Medicare Part D claims. They cover 8 drugs, with $9,964 in total drug cost. In 2022, CMS named 364 claims across 19 drugs.

Dr. Sotolongo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Sotolongo to 1 clinical trial. Conditions studied include Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive.

CMS Open Payments shows 9 general payments to Dr. Sotolongo from 5 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $674. It also lists 4 research payments totaling $170,000 in 2016.